EcoDrugPlus

Proteasome 26s Subunit, Non-Atpase 8

Ensembl ID : ENSBGRG00000026638
Gene Symbol: PSMD8
1 Cross references
209 Possible Orthologues:

Proteasome Subunit Beta 11

Ensembl ID : ENSBGRG00000005418
Gene Symbol: PSMB11
1 Cross references
228 Possible Orthologues:

Protein Arginine Methyltransferase 5

Ensembl ID : ENSBGRG00000004439
Gene Symbol: PRMT5
1 Cross references
199 Possible Orthologues:

Protein Kinase C Alpha

Ensembl ID : ENSBGRG00000018161
Gene Symbol: PRKCA
1 Cross references
213 Possible Orthologues:

Protein Kinase C Beta

Ensembl ID : ENSBGRG00000021867
Gene Symbol: PRKCB
1 Cross references
299 Possible Orthologues:

Protein Kinase C Delta

Ensembl ID : ENSBGRG00000018341
Gene Symbol: PRKCD
1 Cross references
283 Possible Orthologues:

Protein Kinase C Epsilon

Ensembl ID : ENSBGRG00000006634
Gene Symbol: PRKCE
1 Cross references
310 Possible Orthologues:

Protein Kinase C Eta

Ensembl ID : ENSBGRG00000009140
Gene Symbol: PRKCH
1 Cross references
241 Possible Orthologues:

Protein Kinase C Gamma

Ensembl ID : ENSBGRG00000021653
Gene Symbol: PRKCG
1 Cross references
200 Possible Orthologues:

Protein Kinase C Iota

Ensembl ID : ENSBGRG00000006256
Gene Symbol: PRKCI
1 Cross references
226 Possible Orthologues:

Protein Kinase C Theta

Ensembl ID : ENSBGRG00000010059
Gene Symbol: PRKCQ
1 Cross references
204 Possible Orthologues:

Protein Kinase C Zeta

Ensembl ID : ENSBGRG00000023856
Gene Symbol: PRKCZ
1 Cross references
201 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).